Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-14

Clinical Trial Update: Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating topical budesonide for eosinophilic esophagitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • budesonide (topical) (budesonide)

Snippet

Sponsor: Ranjan Dohil | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED | Results posted: 2019-08-14